lanadelumab-flyo

FDA Drug Profile — TAKHZYRO

lanadelumab-flyo is listed in the FDA National Drug Code directory with 8 NDC codes, marketed under brand name including TAKHZYRO. Available dosage forms: solution, injection, solution.

Drug details

Generic Name
lanadelumab-flyo
Brand Names
TAKHZYRO
Application Number
BLA761090
Sponsor
Takeda Pharmaceuticals America, Inc.
NDC Codes
8
Dosage Forms
SOLUTION, INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients
LANADELUMAB

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.